In the last 12 months, insiders at ARVINAS, INC. ($ARVN) filed 153 transactions with the SEC: 2 open-market purchases totaling $495,080 and 35 sales totaling $2,588,639. Net insider sentiment: net selling.
ARVINAS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Houston John G (President and CEO) — 12 transactions totaling $941,930
- Morrison Briggs (Director) — 8 transactions totaling $495,080
- Houston John G (Director) — 3 transactions totaling $466,154
- Taylor Ian (Chief Scientific Officer) — 13 transactions totaling $243,100
- Berkowitz Noah (Chief Medical Officer) — 11 transactions totaling $213,398
View all SEC Filings for ARVINAS, INC. (ARVN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | Berkowitz Noah | Chief Medical Officer | S | Common Stock | 6435 | $11.10 | 202,503.0000 | 73,400,000 | 3.08% | 0.01% |
| Feb. 26, 2026 | Teel Randy | President and CEO | A | Common Stock | 147179 | $0.00 | 296,875.0000 | 73,400,000 | 98.32% | 0.20% |
| March 6, 2026 | Morrison Briggs | Director | P | Common Stock | 20000 | $13.40 | 96,021.0000 | 73,400,000 | 26.31% | 0.03% |
| Feb. 26, 2026 | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 45000 | $0.00 | 192,623.0000 | 73,400,000 | 30.48% | 0.06% |
| Feb. 26, 2026 | Loomis David K | VP, Chief Accounting Officer | A | Common Stock | 12420 | $0.00 | 42,112.0000 | 73,400,000 | 41.83% | 0.02% |
| Feb. 26, 2026 | Teel Randy | President and CEO | A | Common Stock | 147791 | $0.00 | 297,487.0000 | 73,400,000 | 98.73% | 0.20% |
| Feb. 26, 2026 | Teel Randy | President and CEO | A | Stock Option (right to buy) | 218691 | $0.00 | 218,691.0000 | 73,400,000 | 9999.99% | 0.30% |
| Feb. 27, 2026 | Houston John G | Director | S | Common Stock | 11787 | $13.14 | 1,122,183.0000 | 73,400,000 | 1.04% | 0.02% |
| Feb. 27, 2026 | Houston John G | Director | S | Common Stock | 18822 | $13.24 | 1,133,970.0000 | 73,400,000 | 1.63% | 0.03% |
| Feb. 27, 2026 | Houston John G | Director | S | Common Stock | 4688 | $13.24 | 1,152,792.0000 | 73,400,000 | 0.41% | 0.01% |
| Feb. 26, 2026 | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 73,400,000 | 9999.99% | 0.09% |
| Feb. 26, 2026 | Saik Andrew | Chief Financial Officer | A | Common Stock | 45000 | $0.00 | 204,267.0000 | 73,400,000 | 28.25% | 0.06% |
| Feb. 26, 2026 | Berkowitz Noah | Chief Medical Officer | A | Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 73,400,000 | 9999.99% | 0.09% |
| Feb. 26, 2026 | Berkowitz Noah | Chief Medical Officer | A | Common Stock | 45000 | $0.00 | 208,938.0000 | 73,400,000 | 27.45% | 0.06% |
| Feb. 26, 2026 | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 73,400,000 | 9999.99% | 0.09% |
| Feb. 26, 2026 | Loomis David K | VP, Chief Accounting Officer | A | Stock Option (right to buy) | 18504 | $0.00 | 18,504.0000 | 73,400,000 | 9999.99% | 0.03% |
| Feb. 23, 2026 | Teel Randy | President and CEO | S | Common Stock | 1038 | $12.16 | 153,444.0000 | 73,400,000 | 0.67% | 0.00% |
| Feb. 23, 2026 | Teel Randy | President and CEO | S | Common Stock | 3748 | $12.16 | 149,696.0000 | 73,400,000 | 2.44% | 0.01% |
| Feb. 23, 2026 | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 2571 | $12.16 | 147,623.0000 | 73,400,000 | 1.71% | 0.00% |
| Feb. 23, 2026 | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 1038 | $12.16 | 150,194.0000 | 73,400,000 | 0.69% | 0.00% |
| Feb. 23, 2026 | Loomis David K | Chief Accounting Officer | S | Common Stock | 1108 | $12.16 | 29,692.0000 | 73,400,000 | 3.60% | 0.00% |
| Feb. 13, 2026 | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 4592 | $11.89 | 151,232.0000 | 73,400,000 | 2.95% | 0.01% |
| Feb. 13, 2026 | Loomis David K | Chief Accounting Officer | S | Common Stock | 1016 | $11.89 | 30,800.0000 | 73,400,000 | 3.19% | 0.00% |
| Feb. 13, 2026 | Berkowitz Noah | Chief Medical Officer | S | Common Stock | 5685 | $11.89 | 163,938.0000 | 73,400,000 | 3.35% | 0.01% |
| Feb. 13, 2026 | Saik Andrew | Chief Financial Officer | S | Common Stock | 5134 | $11.89 | 159,267.0000 | 73,400,000 | 3.12% | 0.01% |
| Feb. 13, 2026 | Teel Randy | President and CEO | S | Common Stock | 4403 | $11.89 | 154,482.0000 | 73,400,000 | 2.77% | 0.01% |
| Nov. 7, 2025 | Loomis David K | Chief Accounting Officer | S | Common Stock | 230 | $9.89 | 31,697.0000 | 73,400,000 | 0.72% | 0.00% |
| Sept. 22, 2025 | Morrison Briggs | Director | P | Common Stock | 30000 | $7.57 | 76,021.0000 | 73,200,000 | 65.19% | 0.04% |
| June 25, 2025 | AGARWAL SUNIL | Director | A | Common Stock | 16025 | $0.00 | 30,166.0000 | 68,800,000 | 113.32% | 0.02% |
| June 25, 2025 | AGARWAL SUNIL | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | Norwalk Leslie V | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | Smaldone Alsup Laurie | Director | A | Common Stock | 16025 | $0.00 | 26,045.0000 | 68,800,000 | 159.93% | 0.02% |
| June 25, 2025 | Smaldone Alsup Laurie | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | Morrison Briggs | Director | A | Common Stock | 16025 | $0.00 | 46,021.0000 | 68,800,000 | 53.42% | 0.02% |
| June 25, 2025 | Morrison Briggs | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | YOUNG JOHN D | Director | A | Common Stock | 16025 | $0.00 | 26,045.0000 | 68,800,000 | 159.93% | 0.02% |
| June 25, 2025 | YOUNG JOHN D | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | Bain Linda | Director | A | Common Stock | 16025 | $0.00 | 26,045.0000 | 68,800,000 | 159.93% | 0.02% |
| June 25, 2025 | Bain Linda | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | Kennedy Edward Moore Jr. | Director | A | Common Stock | 16025 | $0.00 | 68,763.0000 | 68,800,000 | 30.39% | 0.02% |
| June 25, 2025 | Kennedy Edward Moore Jr. | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | Cunningham Everett | Director | A | Common Stock | 16025 | $0.00 | 26,045.0000 | 68,800,000 | 159.93% | 0.02% |
| June 25, 2025 | Cunningham Everett | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| June 25, 2025 | Norwalk Leslie V | Director | A | Common Stock | 16025 | $0.00 | 26,045.0000 | 68,800,000 | 159.93% | 0.02% |
| June 24, 2025 | Saik Andrew | Chief Financial Officer | S | Common Stock | 5700 | $7.61 | 164,401.0000 | 68,800,000 | 3.35% | 0.01% |
| June 17, 2025 | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 2583 | $7.49 | 154,248.0000 | 68,800,000 | 1.65% | 0.00% |
| May 9, 2025 | Saik Andrew | Chief Financial Officer | A | Common Stock | 59600 | $0.00 | 170,101.0000 | 68,800,000 | 53.94% | 0.09% |
| May 9, 2025 | Loomis David K | Chief Accounting Officer | A | Stock Option (right to buy) | 18100 | $0.00 | 18,100.0000 | 68,800,000 | 9999.99% | 0.03% |
| May 9, 2025 | Loomis David K | Chief Accounting Officer | A | Common Stock | 11825 | $0.00 | 30,688.0000 | 68,800,000 | 62.69% | 0.02% |
| May 9, 2025 | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 68,800,000 | 9999.99% | 0.13% |
| May 9, 2025 | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 68,800,000 | 9999.99% | 0.13% |
| May 9, 2025 | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 59600 | $0.00 | 156,831.0000 | 68,800,000 | 61.30% | 0.09% |
| May 9, 2025 | Berkowitz Noah | Chief Medical Officer | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 68,800,000 | 9999.99% | 0.13% |
| May 9, 2025 | Berkowitz Noah | Chief Medical Officer | A | Common Stock | 59600 | $0.00 | 169,623.0000 | 68,800,000 | 54.17% | 0.09% |
| March 18, 2025 | Berkowitz Noah | Chief Medical Officer | S | Common Stock | 8658 | $8.59 | 110,023.0000 | 68,800,000 | 7.30% | 0.01% |
| Feb. 24, 2025 | Loomis David K | Chief Accounting Officer | S | Common Stock | 1214 | $16.75 | 18,863.0000 | 68,800,000 | 6.05% | 0.00% |
| Feb. 24, 2025 | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 3061 | $16.75 | 98,377.0000 | 68,800,000 | 3.02% | 0.00% |
| Feb. 24, 2025 | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 1146 | $16.55 | 97,231.0000 | 68,800,000 | 1.16% | 0.00% |
| Feb. 24, 2025 | Taylor Ian | President, R&D | S | Common Stock | 7356 | $16.75 | 160,785.0000 | 68,800,000 | 4.37% | 0.01% |
| Feb. 24, 2025 | Taylor Ian | President, R&D | S | Common Stock | 1664 | $16.55 | 159,121.0000 | 68,800,000 | 1.03% | 0.00% |
| Feb. 24, 2025 | Houston John G | President and CEO | S | Common Stock | 26184 | $16.75 | 1,162,634.0000 | 68,800,000 | 2.20% | 0.04% |
| Feb. 24, 2025 | Houston John G | President and CEO | S | Common Stock | 5154 | $16.55 | 1,157,480.0000 | 68,800,000 | 0.44% | 0.01% |
| Feb. 13, 2025 | Loomis David K | Chief Accounting Officer | A | Common Stock | 10584 | $0.00 | 18,624.0000 | 68,800,000 | 131.64% | 0.02% |
| Feb. 13, 2025 | Berkowitz Noah | Chief Medical Officer | A | Common Stock | 55229 | $0.00 | 118,681.0000 | 68,800,000 | 87.04% | 0.08% |
| Feb. 13, 2025 | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 74960 | $0.00 | 74,960.0000 | 68,800,000 | 9999.99% | 0.11% |
| Feb. 13, 2025 | Saik Andrew | Chief Financial Officer | A | Common Stock | 49092 | $0.00 | 110,501.0000 | 68,800,000 | 79.94% | 0.07% |
| Feb. 13, 2025 | Loomis David K | Chief Accounting Officer | A | Stock Option (right to buy) | 16176 | $0.00 | 16,176.0000 | 68,800,000 | 9999.99% | 0.02% |
| Feb. 13, 2025 | Taylor Ian | Chief Scientific Officer | A | Common Stock | 20619 | $0.00 | 168,141.0000 | 68,800,000 | 13.98% | 0.03% |
| Feb. 13, 2025 | Taylor Ian | Chief Scientific Officer | A | Stock Option (right to buy) | 31483 | $0.00 | 31,483.0000 | 68,800,000 | 9999.99% | 0.05% |
| Feb. 13, 2025 | Berkowitz Noah | Chief Medical Officer | A | Stock Option (right to buy) | 84330 | $0.00 | 84,330.0000 | 68,800,000 | 9999.99% | 0.12% |
| Feb. 13, 2025 | Houston John G | President and CEO | A | Stock Option (right to buy) | 232000 | $0.00 | 232,000.0000 | 68,800,000 | 9999.99% | 0.34% |
| Feb. 13, 2025 | Houston John G | President and CEO | A | Common Stock | 152000 | $0.00 | 1,188,681.0000 | 68,800,000 | 14.66% | 0.22% |
| Feb. 13, 2025 | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 74960 | $0.00 | 74,960.0000 | 68,800,000 | 9999.99% | 0.11% |
| Feb. 13, 2025 | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 49092 | $0.00 | 100,944.0000 | 68,800,000 | 94.68% | 0.07% |
| Nov. 7, 2024 | Loomis David K | Chief Accounting Officer | S | Common Stock | 231 | $27.69 | 8,040.0000 | 68,700,000 | 2.79% | 0.00% |
| Nov. 8, 2023 | Loomis David K | Chief Accounting Officer | S | Common Stock | 229 | $17.05 | 8,271.0000 | 53,200,000 | 2.69% | 0.00% |
| June 24, 2024 | Saik Andrew | Chief Financial Officer | A | Common Stock | 61409 | $0.00 | 61,409.0000 | 68,000,000 | 9999.99% | 0.09% |
| June 24, 2024 | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 94418 | $0.00 | 94,418.0000 | 68,000,000 | 9999.99% | 0.14% |
| June 17, 2024 | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 15995 | $0.00 | 51,852.0000 | 68,000,000 | 44.61% | 0.02% |
| June 17, 2024 | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 24632 | $0.00 | 24,632.0000 | 68,000,000 | 9999.99% | 0.04% |
| May 29, 2024 | Kennedy Edward Moore Jr. | Director | A | Common Stock | 5899 | $0.00 | 52,738.0000 | 68,000,000 | 12.59% | 0.01% |
| May 29, 2024 | Cunningham Everett | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | Kennedy Edward Moore Jr. | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | AGARWAL SUNIL | Director | A | Common Stock | 5899 | $0.00 | 14,141.0000 | 68,000,000 | 71.57% | 0.01% |
| May 29, 2024 | AGARWAL SUNIL | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | Morrison Briggs | Director | A | Common Stock | 5899 | $0.00 | 29,996.0000 | 68,000,000 | 24.48% | 0.01% |
| May 29, 2024 | Morrison Briggs | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | YOUNG JOHN D | Director | A | Common Stock | 5899 | $0.00 | 10,020.0000 | 68,000,000 | 143.14% | 0.01% |
| May 29, 2024 | YOUNG JOHN D | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | Norwalk Leslie V | Director | A | Common Stock | 5899 | $0.00 | 10,020.0000 | 68,000,000 | 143.14% | 0.01% |
| May 29, 2024 | Norwalk Leslie V | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | Smaldone Alsup Laurie | Director | A | Common Stock | 5899 | $0.00 | 10,020.0000 | 68,000,000 | 143.14% | 0.01% |
| May 29, 2024 | Smaldone Alsup Laurie | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | Cunningham Everett | Director | A | Common Stock | 5899 | $0.00 | 10,020.0000 | 68,000,000 | 143.14% | 0.01% |
| May 29, 2024 | Bain Linda | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 29, 2024 | Bain Linda | Director | A | Common Stock | 5899 | $0.00 | 10,020.0000 | 68,000,000 | 143.14% | 0.01% |
| May 21, 2024 | Teel Randy | Int. Chief Financial Officer | A | Stock Option (right to buy) | 19675 | $0.00 | 19,675.0000 | 68,000,000 | 9999.99% | 0.03% |
| May 21, 2024 | Teel Randy | Int. Chief Financial Officer | A | Common Stock | 13300 | $0.00 | 59,341.0000 | 68,000,000 | 28.89% | 0.02% |
| March 18, 2024 | Berkowitz Noah | Chief Medical Officer | A | Stock Option (right to buy) | 93879 | $0.00 | 93,879.0000 | 68,000,000 | 9999.99% | 0.14% |
| March 18, 2024 | Berkowitz Noah | Chief Medical Officer | A | Common Stock | 63452 | $0.00 | 63,452.0000 | 68,000,000 | 9999.99% | 0.09% |
| Feb. 23, 2024 | Peck Ronald | Chief Medical Officer | A | Common Stock | 39250 | $0.00 | 69,215.0000 | 68,000,000 | 130.99% | 0.06% |
| Feb. 23, 2024 | Peck Ronald | Chief Medical Officer | S | Common Stock | 1699 | $47.05 | 67,516.0000 | 68,000,000 | 2.45% | 0.00% |
| Feb. 23, 2024 | Peck Ronald | Chief Medical Officer | A | Stock Option (right to buy) | 58100 | $0.00 | 58,100.0000 | 68,000,000 | 9999.99% | 0.09% |
| Feb. 23, 2024 | Taylor Ian | Chief Scientific Officer | A | Common Stock | 39250 | $0.00 | 149,223.0000 | 68,000,000 | 35.69% | 0.06% |
| Feb. 23, 2024 | Taylor Ian | Chief Scientific Officer | S | Common Stock | 1701 | $47.05 | 147,522.0000 | 68,000,000 | 1.14% | 0.00% |
| Feb. 23, 2024 | Taylor Ian | Chief Scientific Officer | A | Stock Option (right to buy) | 58100 | $0.00 | 58,100.0000 | 68,000,000 | 9999.99% | 0.09% |
| Feb. 23, 2024 | Houston John G | President and CEO | A | Common Stock | 124450 | $0.00 | 1,041,877.0000 | 68,000,000 | 13.57% | 0.18% |
| Feb. 23, 2024 | Houston John G | President and CEO | S | Common Stock | 5196 | $47.05 | 1,036,681.0000 | 68,000,000 | 0.50% | 0.01% |
| Feb. 23, 2024 | Houston John G | President and CEO | A | Stock Option (right to buy) | 184200 | $0.00 | 184,200.0000 | 68,000,000 | 9999.99% | 0.27% |
| Feb. 23, 2024 | Cassidy Sean A | Chief Financial Officer | S | Common Stock | 1702 | $47.05 | 181,916.0000 | 68,000,000 | 0.93% | 0.00% |
| Feb. 23, 2024 | Loomis David K | Chief Accounting Officer | A | Stock Option (right to buy) | 8750 | $0.00 | 8,750.0000 | 68,000,000 | 9999.99% | 0.01% |
| Feb. 23, 2024 | Loomis David K | Chief Accounting Officer | A | Common Stock | 5750 | $0.00 | 8,500.0000 | 68,000,000 | 209.09% | 0.01% |
| Jan. 4, 2024 | Taylor Ian | Chief Scientific Officer | M | Stock Option (right to buy) | 0 | $0.00 | 2,065.0000 | 68,000,000 | 0.00% | 0.00% |
| Jan. 4, 2024 | Taylor Ian | Chief Scientific Officer | M | Stock Option (right to buy) | 0 | $0.00 | 10,519.0000 | 68,000,000 | 0.00% | 0.00% |
| Jan. 4, 2024 | Taylor Ian | Chief Scientific Officer | M | Common Stock | 8252 | $16.00 | 109,973.0000 | 68,000,000 | 8.11% | 0.01% |
| Aug. 11, 2023 | Peck Ronald | Chief Medical Officer | S | Common Stock | 1324 | $24.39 | 29,965.0000 | 53,200,000 | 4.23% | 0.00% |
| Aug. 11, 2023 | Peck Ronald | Chief Medical Officer | M | Restricted Stock Units | 4010 | $0.00 | 0.0000 | 53,200,000 | 100.00% | 0.01% |
| Aug. 11, 2023 | Peck Ronald | Chief Medical Officer | M | Common Stock | 4010 | $0.00 | 31,289.0000 | 53,200,000 | 14.70% | 0.01% |
| June 15, 2023 | AGARWAL SUNIL | Director | A | Stock Option (right to buy) | 24948 | $0.00 | 24,948.0000 | 53,200,000 | 9999.99% | 0.05% |
| June 15, 2023 | YOUNG JOHN D | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | Smaldone Alsup Laurie | Director | A | Common Stock | 4121 | $0.00 | 4,121.0000 | 53,200,000 | 9999.99% | 0.01% |
| June 15, 2023 | Smaldone Alsup Laurie | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | Norwalk Leslie V | Director | A | Common Stock | 4121 | $0.00 | 4,121.0000 | 53,200,000 | 9999.99% | 0.01% |
| June 15, 2023 | Norwalk Leslie V | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | Morrison Briggs | Director | A | Common Stock | 4121 | $0.00 | 24,097.0000 | 53,200,000 | 20.63% | 0.01% |
| June 15, 2023 | Morrison Briggs | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | Kennedy Edward Moore Jr. | Director | A | Common Stock | 4121 | $0.00 | 46,839.0000 | 53,200,000 | 9.65% | 0.01% |
| June 15, 2023 | Kennedy Edward Moore Jr. | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | DIXON WENDY L | Director | A | Common Stock | 4121 | $0.00 | 9,121.0000 | 53,200,000 | 82.42% | 0.01% |
| June 15, 2023 | DIXON WENDY L | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | Bain Linda | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | AGARWAL SUNIL | Director | A | Common Stock | 8242 | $0.00 | 8,242.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | YOUNG JOHN D | Director | A | Common Stock | 4121 | $0.00 | 4,121.0000 | 53,200,000 | 9999.99% | 0.01% |
| June 15, 2023 | Cunningham Everett | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| June 15, 2023 | Bain Linda | Director | A | Common Stock | 4121 | $0.00 | 4,121.0000 | 53,200,000 | 9999.99% | 0.01% |
| June 15, 2023 | Cunningham Everett | Director | A | Common Stock | 4121 | $0.00 | 4,121.0000 | 53,200,000 | 9999.99% | 0.01% |
| March 1, 2023 | Taylor Ian | Chief Scientific Officer | M | Common Stock | 2685 | $0.00 | 102,772.0000 | 53,200,000 | 2.68% | 0.01% |
| March 1, 2023 | Cassidy Sean A | Chief Financial Officer | M | Restricted Stock Units | 4791 | $0.00 | 0.0000 | 53,200,000 | 100.00% | 0.01% |
| March 1, 2023 | Cassidy Sean A | Chief Financial Officer | S | Common Stock | 1745 | $29.53 | 183,618.0000 | 53,200,000 | 0.94% | 0.00% |
| March 1, 2023 | Cassidy Sean A | Chief Financial Officer | M | Common Stock | 4791 | $0.00 | 185,363.0000 | 53,200,000 | 2.65% | 0.01% |
| March 1, 2023 | Houston John G | President and CEO | M | Restricted Stock Units | 17510 | $0.00 | 0.0000 | 53,200,000 | 100.00% | 0.03% |
| March 1, 2023 | Houston John G | President and CEO | S | Common Stock | 5878 | $29.53 | 917,427.0000 | 53,200,000 | 0.64% | 0.01% |
| March 1, 2023 | Houston John G | President and CEO | M | Common Stock | 17510 | $0.00 | 923,305.0000 | 53,200,000 | 1.93% | 0.03% |
| March 1, 2023 | Taylor Ian | Chief Scientific Officer | M | Restricted Stock Units | 2685 | $0.00 | 0.0000 | 53,200,000 | 100.00% | 0.01% |
| March 1, 2023 | Taylor Ian | Chief Scientific Officer | S | Common Stock | 1051 | $29.53 | 101,721.0000 | 53,200,000 | 1.02% | 0.00% |
| Feb. 22, 2023 | Taylor Ian | Chief Scientific Officer | A | Common Stock | 19125 | $0.00 | 100,087.0000 | 53,200,000 | 23.62% | 0.04% |
| Feb. 22, 2023 | Houston John G | President and CEO | A | Stock Option (right to buy) | 186250 | $0.00 | 186,250.0000 | 53,200,000 | 9999.99% | 0.35% |
| Feb. 22, 2023 | Houston John G | President and CEO | A | Common Stock | 61975 | $0.00 | 905,795.0000 | 53,200,000 | 7.34% | 0.12% |
| Feb. 22, 2023 | Peck Ronald | Chief Medical Officer | A | Stock Option (right to buy) | 57450 | $0.00 | 57,450.0000 | 53,200,000 | 9999.99% | 0.11% |
| Feb. 22, 2023 | Peck Ronald | Chief Medical Officer | A | Common Stock | 19125 | $0.00 | 27,279.0000 | 53,200,000 | 234.55% | 0.04% |
| Feb. 22, 2023 | Cassidy Sean A | Chief Financial Officer | A | Stock Option (right to buy) | 57450 | $0.00 | 57,450.0000 | 53,200,000 | 9999.99% | 0.11% |
| Feb. 22, 2023 | Cassidy Sean A | Chief Financial Officer | A | Common Stock | 19125 | $0.00 | 180,572.0000 | 53,200,000 | 11.85% | 0.04% |
| Feb. 22, 2023 | Taylor Ian | Chief Scientific Officer | A | Stock Option (right to buy) | 57450 | $0.00 | 57,450.0000 | 53,200,000 | 9999.99% | 0.11% |